125 related articles for article (PubMed ID: 10066850)
1. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage.
van Kooten F; Ciabattoni G; Koudstaal PJ; Dippel DW; Patrono C
Stroke; 1999 Mar; 30(3):546-9. PubMed ID: 10066850
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation and lipid peroxidation in patients with acute ischemic stroke.
van Kooten F; Ciabattoni G; Patrono C; Dippel DW; Koudstaal PJ
Stroke; 1997 Aug; 28(8):1557-63. PubMed ID: 9259748
[TBL] [Abstract][Full Text] [Related]
3. Increased thromboxane biosynthesis in patients with acute cerebral ischemia.
Koudstaal PJ; Ciabattoni G; van Gijn J; Nieuwenhuis HK; de Groot PG; Sixma JJ; Patrono C
Stroke; 1993 Feb; 24(2):219-23. PubMed ID: 8421822
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
5. Evidence for episodic platelet activation in acute ischemic stroke.
van Kooten F; Ciabattoni G; Patrono C; Schmitz PI; van Gijn J; Koudstaal PJ
Stroke; 1994 Feb; 25(2):278-81. PubMed ID: 8303731
[TBL] [Abstract][Full Text] [Related]
6. Increased thromboxane biosynthesis is associated with poststroke dementia.
van Kooten F; Ciabattoni G; Koudstaal PJ; Grobbee DE; Kluft C; Patrono C
Stroke; 1999 Aug; 30(8):1542-7. PubMed ID: 10436098
[TBL] [Abstract][Full Text] [Related]
7. Mediterranean diet reduces thromboxane A2 production in atrial fibrillation patients.
Pignatelli P; Pastori D; Farcomeni A; Nocella C; Bartimoccia S; Vicario T; Bucci T; Carnevale R; Violi F
Clin Nutr; 2015 Oct; 34(5):899-903. PubMed ID: 25288566
[TBL] [Abstract][Full Text] [Related]
8. Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction.
Uyama O; Shimizu S; Nakanishi T; Nakahama H; Takiguchi A; Hayashi Y; Yamamoto S; Sugita M
Intern Med; 1992 Jun; 31(6):735-9. PubMed ID: 1392173
[TBL] [Abstract][Full Text] [Related]
9. Increased thromboxane biosynthesis in essential thrombocythemia.
Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
[TBL] [Abstract][Full Text] [Related]
10. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo.
Landolfi R; Ciabattoni G; Patrignani P; Castellana MA; Pogliani E; Bizzi B; Patrono C
Blood; 1992 Oct; 80(8):1965-71. PubMed ID: 1327286
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids impair platelet thromboxane biosynthesis in community-acquired pneumonia.
Cangemi R; Carnevale R; Nocella C; Calvieri C; Cammisotto V; Novo M; Castellani V; D'Amico A; Zerbinati C; Stefanini L; Violi F;
Pharmacol Res; 2018 May; 131():66-74. PubMed ID: 29577968
[TBL] [Abstract][Full Text] [Related]
12. Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation.
Pastori D; Pignatelli P; Farcomeni A; Cangemi R; Hiatt WR; Bartimoccia S; Nocella C; Vicario T; Bucci T; Carnevale R; Lip GY; Violi F
Am Heart J; 2015 Sep; 170(3):490-7.e1. PubMed ID: 26385032
[TBL] [Abstract][Full Text] [Related]
13. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.
Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G
J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.
Davì G; Gresele P; Violi F; Basili S; Catalano M; Giammarresi C; Volpato R; Nenci GG; Ciabattoni G; Patrono C
Circulation; 1997 Jul; 96(1):69-75. PubMed ID: 9236419
[TBL] [Abstract][Full Text] [Related]
15. What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?
Dippel DW; Van Kooten F; Leebeek FW; van Vliet HH; Mehicevic A; Li SS; Koudstaal PJ
Cerebrovasc Dis; 2004; 17(4):296-302. PubMed ID: 15026612
[TBL] [Abstract][Full Text] [Related]
16. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
[TBL] [Abstract][Full Text] [Related]
17. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
Davì G; Basili S; Vieri M; Cipollone F; Santarone S; Alessandri C; Gazzaniga P; Cordova C; Violi F
Am J Respir Crit Care Med; 1997 Dec; 156(6):1794-9. PubMed ID: 9412557
[TBL] [Abstract][Full Text] [Related]
18. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man.
Ciabattoni G; Pugliese F; Davi G; Pierucci A; Simonetti BM; Patrono C
Biochim Biophys Acta; 1989 Jul; 992(1):66-70. PubMed ID: 2752040
[TBL] [Abstract][Full Text] [Related]
19. Paired analysis of urinary thromboxane B2 metabolites in humans.
Catella F; FitzGerald GA
Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
[TBL] [Abstract][Full Text] [Related]
20. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
